SILO PHARMA, INC. Intangible Assets, Net (Excluding Goodwill)
SILO PHARMA, INC. (SILO) had Intangible Assets, Net (Excluding Goodwill) of $211.50 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-13
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $211.50K.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $214.44K.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $217.38K.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $220.31K.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2026-06-30 | $211.50K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $214.44K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $217.38K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $220.31K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $223.25K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $238.12K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $241.22K POS AM · filed 2026-04-14 |
| 2024-09-30 | $244.31K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $247.40K 10-Q · filed 2024-08-13 |
| 2019-09-30 | $29.44K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $29.44K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $29.44K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $29.44K 10-K · filed 2020-03-20 |
| 2018-09-30 | $282.50K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |